Journal of Oral & Facial Pain and Headache. 2025; 39(1): 49-69. doi: 10.22514/jofph.2025.004
Systematic Review

Pseudogout of the temporomandibular joint: a case report with systematic literature review

Matteo Val1,*,, Mirko Ragazzo2, Anna Colonna1, Marco Ferrari1, Edoardo Ferrari Cagidiaco1, Daniele Manfredini1, Luca Guarda Nardini2

1Department of Biomedical Technologies, School of Dental Medicine, University of Siena, 53100 Siena, Italy

2Unit of Oral and Maxillofacial Surgery, Ca’Foncello Hospital, 31100 Treviso, Italy

*Corresponding Author(s):matteo.val@outlook.it (Matteo Val)

History Submitted: 17 July 2024 | Accepted: 12 October 2024 | Published: 12 March 2025
Copyright:  ©2025  The Author(s). Published by MRE Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).

Collapse table of contents

Abstract

Background: Calcium pyrophosphate dihydrate deposition disease (CPPD) is a metabolic disease resulting in acute arthritis. CPPD often affects joints containing fibrocartilage. The purpose of this review is to examine the clinical presentations, prevalence, and treatment modalities associated with CPPD when it affects the temporomandibular joint (TMJ). Methods: A search, following PRISMA guideline, was conducted in various electronic databases (PubMed, Scopus, Web of Science) to find relevant studies about CPPD in the temporomandibular joint. The search spanned from 01 January 1980, to 31 January 2024. A case report was also presented. Results: A systematic review of literature identified 64 papers, reaching a total of 74 cases of CPPD of the temporomandibular joint TMJ. CPPD is a condition that typically affects middle-aged or older patients, with an average age of around 60 at the time of diagnosis. Females are affected more frequently than males. Most cases involve unilateral TMJ involvement, and common symptoms include pain, reduced mouth opening, and swelling. Different papers also describe severe stages of the invasion of muscles, parotid gland, and even brain structure. Surgery has the preferred treatment option for most Authors and is mandatory for late-stage lesions. The recurrence rate is extremely low. Conclusions: CPPD is an uncommon, locally invasive, and typically benign condition that rarely affects the TMJ. Distinguishing CPDD in the TMJ from other neoplasms poses diagnostic challenges. A definitive diagnosis necessitates histological examination and quantitative microanalysis. In our patient, successful excision of CPDD in the TMJ was achieved using an external approach. The PROSPERO Registration: PROSPERO number is CRD42024558402.

Keywords:Calcium pyrophosphate dihydrate deposition disease;Pseudogout;Temporomandibular joint;Systematic review;Epidemiology
PDF(1.79 MB)|EndNote (RIS)|BibTeX|RefMan|RefWorks

Cite this article

Matteo Val, Mirko Ragazzo, Anna Colonna, Marco Ferrari, Edoardo Ferrari Cagidiaco, Daniele Manfredini, Luca Guarda Nardini. Pseudogout of the temporomandibular joint: a case report with systematic literature review. Journal of Oral & Facial Pain and Headache. 2025; 39(1): 49-69. doi: 10.22514/jofph.2025.004

1. Introduction

Calcium pyrophosphate dihydrate deposition disease (CPPD) is a metabolic disorder that causes non-infectious inflammation in joints and can lead to calcification either within or around the joint [1]. In 1962, Kohn et al. [2] were the first to document the presence of CPPD crystals in the synovial fluid of the knee in patients with “chondrocalcinosis”, characterized by cartilage calcifications on standard radiographs [3] along with acute symptoms associated with gout. Chondrocalcinosis is commonly used as a marker for the presence of CPPD in population-based studies, and its occurrence is closely linked to aging. Radiological evidence of chondrocalcinosis is observed in 6% to 15% of patients above the age of 60. This prevalence increases to 30% to 40% in patients aged over 80 years [1]. Despite the knowledge on the disease, many instances are probably not being diagnosed correctly [4].

Furthermore, Willekens et al. [5] pointed out that individuals with peripheral calcific disease are more likely to have involvement of the temporomandibular joint (TMJ) than previously believed.

The involvement of the TMJ by CPPD exhibits signs and symptoms that closely resemble various other temporomandibular joint disorders. Consequently, inexperienced professionals may attempt multiple management approaches, often resulting in a delayed or missed diagnosis [6, 7], which is a common occurrence in this type of pathology [8, 9, 10, 11]. Therefore, accurate classification of the patient using evidence-based methods is imperative [12, 13, 14].

Information on CPPD is currently limited. The prevalence of this condition remains unknown, and milder forms may be underdiagnosed. Additionally, effective treatment for CPPD affecting the temporomandibular joints has yet to be established, unlike for other joint involvements.

Based on this premise, it seems interesting to get deeper into the description of pseudogout of the TMJ. In this manuscript, we report a clinical case of large TMJ pseudogout as well as a systematic review of the existing literature, with the aim to share information about the prevalence, management and follow-up of patients with CPPD.

2. Case presentation

An 87-year-old Caucasian female was referred to the Unit of Oral and Maxillofacial Surgery in September 2022 for the evaluation of a firm swelling located over her left TMJ. The patient had been experiencing chronic left TMJ pain for over 2 years. Despite seeking medical advice from multiple healthcare providers during this period, she did not receive a definitive diagnosis. Her dentist tried different medical treatment, including anti-inflammatory (ibuprofen) associated with amoxicillin + clavulanic acid 875 + 125 mg (1 pill every 8 hours for 7 days), without success. Then a second dentist produced an oral device trying to reduce overload and the swelling to the TMJ, but there were no improvements. Her past medical history includes diabetes, hypercholesterolemia and hypoacusia. She was receiving treatment that included aspirin, insulin, metformin, gliclazide and statins. The patient denied any history of trauma or infection to the jaw area.

Upon examination, a localized swelling was identified in the left pre-auricular region, measuring approximately 30 mm. The area exhibited tenderness upon palpation and showed a firm, bony texture. The patient complained of mouth limitation and lateral deviation of the mandible when mouth opening. No other symptoms were reported by the patient.

A computerized tomography (CT) was performed due to the suspect of a neoformation of the left TMJ. From the radiological examination was highlighted a massive radiopaque lesion (major diameter 39 mm) was shown that embroidered the head of the left condyle, which appeared degenerated as the glenoid fossa, with some minor defects also evident in the roof of the fossa (Fig. 1). Based on the patient’s primary clinical characteristics and radiological findings, the differential diagnosis included tumor or tumor-like conditions, such as pigmented villonodular synovitis (PVNS), synovial chondromatosis, and the potential for malignant chondrosarcoma of the right temporomandibular joint (TMJ). The patient underwent surgical removal of the mass under general anaesthesia through a preauricular approach followed by tissue dissection. During the procedure, the mass was found to be an encapsulated soft tissue mass originating and surrounding from the circumference of the articular disk (Fig. 2). Once the capsule was cute a nodular, friable, gritty granulomatous tissue emerged. It was excised in two separate portions. Arthroplasty was performed using a burr to re-establish the correct shape of the mandibular condyle. The incision is subsequently closed using layered sutures. Upon microscopic examination, it was observed that there were nodules of birefringent crystalline material and calcifications present, which were associated with reactive chondroblasts and histiocytes. The integrity of the crystals during processing indicated the presence of calcium pyrophosphate crystal deposition, known as pseudogout, in the TMJ. The patient had a smooth recovery with no facial weakness and reported an increase in maximal inter-incisal opening from 19 mm to 36 mm during the one-year follow-up examination after surgery. Leftward deviation of the mandible only occurred at maximum opening, and there were no changes in occlusion reported. Pain and swelling had completely resolved.

Radiographic evaluation pre and 
post-surgical excision. (A) illustrates the coronal view of a computed 
tomography (CT) scan prior to surgical intervention, while (B) represents 
the axial view of the CT scan before surgery. Conversely, (C) depicts the 
radiological findings following the surgical excision of the lesion in a coronal 
view, and (D) presents the axial view of the CT scan.

Fig. 1.Radiographic evaluation pre and post-surgical excision. (A) illustrates the coronal view of a computed tomography (CT) scan prior to surgical intervention, while (B) represents the axial view of the CT scan before surgery. Conversely, (C) depicts the radiological findings following the surgical excision of the lesion in a coronal view, and (D) presents the axial view of the CT scan.

Surgical excision. (A) shows 
the clinical appearance following surgical removal of superficial tissue over the 
temporomandibular joint (TMJ), displaying nodular, friable, gritty granulomatous 
tissue. (B) represents the surgical specimens, and (C) shows the TMJ with the 
mass completely removed.

Fig. 2.Surgical excision. (A) shows the clinical appearance following surgical removal of superficial tissue over the temporomandibular joint (TMJ), displaying nodular, friable, gritty granulomatous tissue. (B) represents the surgical specimens, and (C) shows the TMJ with the mass completely removed.

3. Materials and methods

3.1 Electronic database search

To find relevant studies about calcium pyrophosphate dihydrate crystal deposition disease in the temporomandibular joint, a search was conducted in the following electronic databases PubMed, Web of Science and Scopus following the PRISMA guidelines [15]. For the PRISMA checklist, please see Supplementary material. The search terms used were “Calcium pyrophosphate dihydrate crystal deposition disease temporomandibular joint”, “CPPD temporomandibular joint” and “Pseudogout temporomandibular joint”. Keywords and Medical Subject Headings (MeSH) terms were used to combine the search on the aforementioned databases. In addition, the “Related articles” option on the PubMed homepage was considered, and a manual search of article references was conducted to capture any additional relevant reports. The search spanned from 01 January 1980, to 31 January 2024. The review has been registered in PROSPERO with the Identification Number (ID) number CRD42024558402. The full list of keywords used are:

- (“chondrocalcinosis” [MeSH Terms] OR “chondrocalcinosis” [All Fields] OR “pseudogout” [All Fields]) AND (“temporomandibular joint” [MeSH Terms] OR (“temporomandibular” [All Fields] AND “joint” [All Fields]) OR “temporomandibular joint” [All Fields])

- (“chondrocalcinosis” [MeSH Terms] OR “chondrocalcinosis” [All Fields] OR (“calcium” [All Fields] AND “pyrophosphate” [All Fields] AND “dihydrate” [All Fields] AND “crystal” [All Fields] AND “deposition” [All Fields] AND “disease” [All Fields]) OR “calcium pyrophosphate dihydrate crystal deposition disease” [All Fields]) AND (“temporomandibular joint” [MeSH Terms] OR (“temporomandibular” [All Fields] AND “joint” [All Fields]) OR “temporomandibular joint” [All Fields])

3.2 Inclusion and exclusion criteria

For the review, only the studies that met the following criteria were included: (i) they were original case series or case reports, (ii) they documented Pseudogout, and (iii) they involved the temporomandibular joint in patients of any age. Articles that are not specific to the topic or are published in languages other than English were excluded; in particular, it was necessary to prevent misinterpretation by authors whose second language is English. Reports involving tumor calcinosis or with insufficient data.

3.3 Data extraction

Two of the authors (MV; AC) thoroughly reviewed literature data and carefully selected all the studies that met the eligibility criteria. All relevant data, such as demographics, clinical characteristics, outcomes and follow-up, were extracted and recorded from each study. Any discrepancies were resolved through discussion with the senior authors (DM, LGN).

3.4 Descriptive analysis

The initial plan was to conduct a meta-analysis for this systematic review. However, since the studies showed a relevant degree of heterogeneity, it was not feasible to proceed with this approach. As a result, a descriptive analysis of the studies was conducted instead.

3.5 Outcome

The main results analyzed in the studies were:

Provide an estimate of the real prevalence of CPPD;

Investigate the co-occurrence of medical conditions and underlying systemic factors that contribute to the development of CPPD;

Describe the most common signs and symptoms related to CPPD;

Identify the most effective treatment option.

Secondary Outcomes were:

Evaluate the presence of relapse;

Highlight the best radiological methods to study this pathology.

3.6 Risk of bias evaluation

Two authors (MV/MR) evaluated these aspects for each study: incomplete data evaluation, evaluation report, and other sources of biased selective results. Each research study underwent classification as either low risk, high risk or undefined risk. Any discrepancies in the assessment process were resolved through deliberation or mediation involving a third researcher (DM).

Regrettably, the presence of solely case reports and case series, along with significant disparities in treatments administered even within the same patient series, precluded a comprehensive assessment of bias.

4. Results

A total of 125 papers were found. After the screening procedures for inclusion in the review, 64 case report/case series were identified. The flowchart depicting the article selection process for all search queries is available in Fig. 3.

Flowchart illustrating the procedure 
for article selection. Legend: CPPD: Calcium pyrophosphate dihydrate deposition 
disease; TMJ: temporomandibular joint.

Fig. 3.Flowchart illustrating the procedure for article selection. Legend: CPPD: Calcium pyrophosphate dihydrate deposition disease; TMJ: temporomandibular joint.

4.1 Population’s characteristics

Table 1 (Ref. [8, 9, 10, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87]) presents the characteristics of the studies included, which were published between 1982 and 2023. These studies encompassed a total of 64 papers, involving 74 patients. Females outnumbered males (F:M = 46:28). The mean age at the moment of diagnosis ranged between 60.95 ± 13.02. Almost all patients (70 out of 74) had a unilateral TMJ involvement. Only 22 had a recorded medical history concerning any possible comorbidities. The three most frequent comorbidities were hypertension, hypercholesterolemia and diabetes. Additionally, there were four cases of patients suffering from gout.

Table 1.Characteristics of the patients.
Study first AuthorYearN of patientsSexAgeLocalizationHistory of the lesionSystemic diseases
Good et al. [20]19821M59Right TMJAcute originNot reported
Zemplenyi et al. [29]19852F51Left TMJNo descriptionNot reported
Gross et al. [30]19873F59Left TMJHistory of generalized arthritis affecting multiple joints, which has been managed with localized steroid injections.Not reported
Hutton et al. [22]19874F78Right TMJAcute originNot reported
5F76Right TMJAcute originNot reported
6F68Right TMJAcute originPolymyalgia rheumatica, for which she had been treated with prednisolone
Kamatani et al. [43]19877M57Left TMJTrauma 6 year before with mild symptomsDiabetes mellitus
Mogi et al. [61]19878F54Right TMJ8 years history of pain and swelling since thel esion was highlightedNot reported
Lambert et al. [32]19909M41Left TMJ18 years since the lesion was highlightedNot reported
Dijkgraaf et al. [44]199210F53Left TMJ8 months before had a loud click in her TMJ with pain and disk displacement at the MRINot reported
Magno et al. [33]199211F53Left TMJThe patient was involved in a motor vehicle accident many years ago, during which she suffered a cervical vertebral fractureNot reported
Chuong et al. [46]199512F65Bilateral TMJThe patient has an 8-year history of bilateral temporomandibular joint (TMJ) pain, periodic popping and locking, and frequent restricted mouth opening, particularly during episodes of frank preauricular swellingHypothyroidism, hypertension, hiatal hernia, and von Willebrand’s disease.
Pynn et al. [45]199513M58Left TMJThe patient presented with a history of swelling persisting for 18 months. The swelling manifested abruptly and maintained its size until one month prior to the referral, when it significantly increased before gradually returning to its original size following a two-week course of oral acetylsalicylic acidNot reported
Allias-Montmayeur et al. [23]199714M52Left TMJPatient presents with a limited mouth opening, mandibular deviation, and pre-auricular swelling persisting for 4 yearsNot reported
15F46Left TMJAcute attack of pain in the left TMJ. Same episode 3 years before. Pre-auricular swellingNot reported
Kurihara et al. [51]199716M85Right TMJSwelling in the right TMJ region, which he had suffered for 2 years. Pain during masticationNot reported
Onodera et al. [69]199717F48Left TMJSwelling for 3 years, restricted mouth openingNot reported
Vargas et al. [70]199718F66Left TMJ2-month history of swelling with tenderness over the left pre-auricular region with pain with restriction of jaw openingNot reported
Jordan et al. [16]199819M80Right TMJThe patient presented with a one-month history of sudden worsening of right-sided hearing loss following descent in an airplane flight. He denied experiencing any temporomandibular joint (TMJ) pain, trismus, jaw popping, or clicking. A right-sided middle ear effusion was observed and treated with myringotomy, but reaccumulated rapidly.Hypertension, hypercholesterolemia, and gout
Strobl et al. [71]199820F51Left TMJThe patient presented with an 18-month history of progressive left-sided temporomandibular joint (TMJ) pain and trismus. There was no reported history of trauma or systemic joint diseaseNot reported
Goudot et al. [72]199921F63Left TMJ10-year history of left TMJ pain and restricted mouth openingNot reported
Grant et al. [28]199922F65Left TMJThe patient presented with a 2- to 3-month history of progressive left-sided facial fullness, discomfort, and intermittent facial swelling. The discomfort was alleviated after a course of antibiotic medications and prednisone for suspected parotiditis, although the swelling persisted. The patient denied experiencing any paresthesias, nasal issues, otalgia, or swallowing difficulties. Her medical history revealed longstanding bilateral middle ear infections, necessitating the placement of a left-sided myringotomy tubeNot reported
Nakagawa et al. [73]199923F60Right TMJThe patient has a 1-year history of swelling in the right preauricular region and has reported a l-month history of TMJ discomfort and trismusNot reported
24F45Left TMJThe patient reported a progressive increase in left temporomandibular joint (TMJ) pain, which commenced several years prior to seeking medical attention. The pain was described as a burning sensation and was exacerbated during jaw movement.Not reported
Pynn et al. [50]199525M58Left TMJThe patient presented with painless swelling in the left preauricular region persisting for approximately 18 months. The swelling had a sudden onset and remained unchanged in size until one month prior to referral, when it abruptly increased before slowly returning to its original size following two weeks of oral acetylsalicylic acid (aspirin) therapyNot reported
Aoyama et al. [74]200026F45Left TMJThe patient presented with painful swelling in the left preauricular area and reported experiencing a clicking noise when opening her mouth for over 30 years. Additionally, eight years ago, she experienced pain in the same area, which subsided following occlusal adjustment and the prescription of a muscle relaxantNot reported
Li-Yu et al. [34]200027F72Left TMJExcruciating pain in her left ear. Initial treatment for suspected otitis media included antibiotics with no improvement noted. The pain gradually extended to her left cheek and jaw, with some localized swelling and tenderness over the TMJ areaHysterectomy in 1985 and breast cancer in 1993
Eriksson et al. [75]200128F72Right TMJThe patient has been experiencing chronic pain in the right TMJ for several years, with the pain intensifying over time and becoming more pronounced during chewing. Additionally, the patient has observed a minor swelling in the joint and has reported experiencing clicking sensations. The patient also recalls experiencing trauma to the chin during childhoodNot reported
Olin et al. [24]200129F51Left TMJThe patient developed a pre-auricular swelling on the left side that has been persistent for two monthsNot reported
Osano et al. [76]200330M40Left TMJThe patient presented with pain and swelling in his left TMJ. He had previously encountered similar symptoms two years ago, which were alleviated with intravenous antibiotic infusionNot reported
Marsot-Dupuch et al. [35]200431F70Right TMJThe patient has a 10-year history of right TMJ pain and an ear lump. She was referred due to acute exacerbation, new onset of left TMJ pain, and right-sided hearing lossNot reported
32M53Left TMJThe patient presents with a 1-year history of acute left aural fullness and conductive hearing loss. Examination revealed otitis media, for which the patient had previously undergone myringotomy and tube placement at an external medical facility, with no improvement in symptoms. The patient denied experiencing otorrhea, otalgia, vertigo or tinnitusDiabetes mellitus
Meul et al. [77]200533M54Left TMJPatient has a 3-year history of painless swelling in the left preauricular regionThe individual experienced paraplegia as a result of a motor-vehicle accident 25 years ago, and also has non-insulin dependent diabetes
Smolka et al. [25]200534F74Left TMJExtremely painful preauricular swelling on the left sideNot reported
Nicholas et al. [52]200735F35Left TMJThe patient presented with a 2-month history of left-sided otalgia and an external auditory canal lesion that did not respond to antibiotic treatment. Additionally, the patient had previously experienced temporomandibular joint (TMJ) pain four years ago and had received an appliance at that time, which proved ineffectiveNot reported
Mikami et al. [78]200836M59Left TMJIn April 2006, the patient experienced intense pain in the left TMJ region. Despite undergoing physical therapy treatment at a previous medical facility, there was no improvement in the symptomsNot reported
Naqvi et al. [36]200837M35Left TMJThe patient has been experiencing discomfort and pain in the TMJ area for the past four years. Additionally, he has been suffering from acute severe pain in his left ear, with a potential pustule within the external auditory canal, in conjunction with TMJ discomfort. Although he received treatment for an ear infection, the lesion in the external auditory canal did not resolveNot reported
Reynolds et al. [79]200838F52Left TMJThe patient presented with longstanding and progressively worsening left TMJ pain. The pain occurred episodically, approximately twice per year, and persisted for 2 weeks during each episode. There were no identifiable precipitating factors. Additionally, the patient experienced regular discomfort when chewing for extended periods on the affected sideNot reported
Covani et al. [9]200939F74Right TMJLimited mouth opening and severe swelling on the right side of the face. The patient had a three-year history of limited mouth opening and painless swellingNot reported
Kathju et al. [80]201040F78Left TMJThe patient has reported experiencing intermittent pain in the left TMJ over the course of several years. Additionally, they have noted a gradual increase in swelling on the left cheek over the past yearHypertension, peripheral vascular disease, history of deep venous thrombosis in both lower extremities, history of bladder cancer, melanoma, transient ischemic attack (TIA), and osteoporosis
Meng et al. [47]201141F64Left TMJ5-year history of chronic pain and swellingHypertension, hypercholesterolaemia and a gallbladder stone.
Sklenicka et al. [26]201142F58Right TMJThe patient presents with a 2-month history of progressive swelling of the right TMJ accompanied by trismus and facial painDepression, for which she was on paroxetine. Previous surgical history was significant for bunionectomy, lower back surgery, and stapedectomy
Matsumura et al. [81]201243M46Right TMJRight temporomandibular painMild depression
Nelson et al. [31]201244F89Right TMJNo descriptionLiposarcoma of the right arm that had been treated with surgical resection 2 years earlier
Srinivasan et al. [27]201245F51Right TMJThe patient presented with a two-month history of left ear pain originating from the TMJ, accompanied by swelling, discomfort while chewing, and mild hearing lossNot reported
Zweifel et al. [48]201246M75Right TMJThe patient experienced a single episode of TMJ open locking in his right jaw while chewing the previous day. The mandible repositioned spontaneously, but the patient subsequently noticed a slight opening in his bite on the same side. Additionally, he reported localized TMJ pain and swellingArterial hypertension, prostate hyperplasia, and malaria in 1994
Lv et al. [17]201347M62Right TMJApproximately five years ago, the patient experienced unexplained swelling in the anterior region of their right external auditory canal. This swelling was not accompanied by localized pain or limitations in mouth opening. Subsequently, over the past two months, the individual noticed a decline in hearing in their right ear, which was not accompanied by symptoms such as tinnitus, ear pain, or discharge from the earHistory of high blood pressure, high cholesterol, high uric acid, chronic ex- tremity pain, gout or arthritis
Abdelsayed et al. [37]201448M60Left TMJLimited mouth opening for several yearsNot reported
49M75Right TMJThe patient has a history of chronic pain in the right jaw accompanied by trismus persisting for 4 years. Over a period of 1 year, the patient experienced pain in the right ear, along with sensations of blockage and thumping tinnitus. Additionally, the patient reported hearing loss and intermittent episodes of positional off-balance sensation. The patient underwent right ear surgery for cholesteatomaNot reported
50F74Left TMJThe patient had been suffering from painful swelling in the left TMJ for five years before seeking medical attention. The pain had intensified significantly in the month leading up to the examination, and the patient had also been experiencing hearing loss in her left earNot reported
Laviv et al. [54]201551F60Right TMJTMJ pain and limited mouth opening for 7 months despite various treatments, affecting daily activitiesGeneralized degenerative joint disease with symptoms in her back, shoulders, and toes. There was a strong family history of arthritis. No specific diagnosis had been made and routine rheumatoid screens were negative. Her medical history was important for allergy to penicillin, asthma, and thyroid disease. She took levothyroxine, omeprazole, and asthma medications as needed
Kudoh et al. [18]201752M38Right TMJThe patient reported experiencing mild pain in the right chin and tip of the tongue. The onset of mild pain in the right chin occurred 2 months prior to admission, following which the patient received root canal treatment for the right lower second molarHyperlipidemia, gout, diabetes, and hyper- tension. These conditions were all well controlled with medication
Fuentes-Martinez et al. [62]201853F89Left TMJThe patient has been experiencing TMJ pain for the past 5 years. She has a history of trauma in that area dating back 40 years; however, the trauma did not necessitate medical attentionNot reported
Kwon et al. [82]201854M72Left TMJThe patient presented with pain and hardening of the area in front of the left ear. He had no significant prior medical conditions and experienced discomfort and crackling sensation when opening his mouth, a condition that had persisted for a couple of yearsNot reported
Vellone et al. [83]201855F64Right TMJRight temporomandibular pain and limitation in mandibular movementsNot reported
De Jong et al. [38]201956M73Left TMJTwitching of the mouth and the sensation of fullness in the left ear, long-standing dizziness and imbalanceNot reported
Fan et al. [39]201957F87Right TMJThe patient presented with complaints of bilateral ear fullness and a sensation of clogged ears accompanied by a slight decrease in hearing over the past 2 months. Additionally, she reported experiencing chronic facial pain that began 2 years ago, which has progressively worsened over the last 4 months. The pain was exacerbated during jaw movement. Furthermore, she noted the presence of pain on the right side of her throat, anosmia, and a loss of ability to taste food over the past 2 monthsChronic kidney disease, congestive heart failure, hypertension, lung nodules, and COPD
Sha et al. [84]201958F57Right TMJRight TMJ pain for more than 5 years.Not reported
Abou-Foul et al. [53]202059M56Left TMJProgressive left sided TMJ discomfort, swelling and trismusNot reported
Choi et al. [19]202060F61Bilateral TMJThe patient presented with initial complaints of bilateral TMJ pain and a history of decreased mouth opening spanning several yearsNot reported
61F66Bilateral TMJThe patient initially reported experiencing limited mouth opening and persistent joint pain subsequent to a motor vehicle accident that occurred 8 months agoHypothyroidism
62M72Right TMJThe patient presented with acute pain in the right TMJ, swelling in front of the ear, and restricted mouth opening. He had a 20-year history of right TMJ disease, which was managed through non-invasive methodsGout, type II diabetes, and essential tremors
Gomez Serrano et al. [40]202063M73Left TMJLeft-sided hearing lossNot reported
Hotokezaka et al. [10]202064F59Left TMJThe patient, with a 4-year history of left cheek swelling, pain and trismus, was referred due to acute exacerbation of left cheek pain and trismusNot reported
Houghton et al. [85]202065F55Right TMJThe patient presents with a painless right-sided pre-auricular mass that has been progressively increasing in size over the past 2 yearsNot reported
Loro et al. [86]202066F40Bilateral TMJThe patient presented with swelling in the left preauricular region. She had a significant history of TMJ pain and restricted jaw movements. Fourteen years prior, she underwent bilateral discectomy and synovectomy. Subsequently, three years ago, she underwent arthroplasty and synovectomy in the right TMJ due to severe pain and substantial reduction in TMJ functionAsthma, hypertension, and psoriatic arthritis with involvement of both TMJs diagnosed over 20 years ago
Tang et al. [41]202167F46Right TMJThe patient has been experiencing persistent pain and discomfort in the right temporal region for a duration exceeding three monthsDiabetes mellitus
68M52Left TMJThe patient has been experiencing a mass in the left TMJ for the past 6 yearsNot reported
Bschorer et al. [8]202269F53Left TMJThe patient presented with progressive pain in the left TMJ and noted a progressive asymmetry of the face attributed to swelling in the left preauricular region. She reported that these symptoms had slowly developed over the past decadeNot reported
Dang et al. [49]202270M65Left TMJThe patient has been experiencing a progressively worsening left posterior open bite and mild, dull, constant left pre-auricular tenderness for the past 4–5 monthsHypertension and ulcerative colitis
Murahashi et al. [87]202271M61Right TMJThe patient has been experiencing persistent preauricular pain in the right cheek and restricted mouth opening for more than 6 monthsHypertension and type 2 diabetes mellitus
Takeda et al. [63]202272F83Right TMJFirst noticed the pain 3 years earlierNot reported
Terauchi et al. [55]202273M47Right TMJPersistent pain in the right TMJ and trismusNot reported
Bukawa et al. [21]202374F73Left TMJAcute swelling at the closure site of the left earHypertension, osteoporosis, and hyperlipidemia, and she has been receiving anti-RANKL preparations for 2 years, she also took an angiotensin II receptor blocker, pravastatin sodium
Legend: M: Male; F: Female; MRI: Magnetic Resonance; COPD: Chronic obstructive pulmonary disease; RANKL: receptor activator of nuclear factor kappa beta ligand.

4.2 Signs and symptoms

Out of the 74 cases, there were only 12 patients [16, 21, 22, 23, 24, 25, 26, 27, 28] reporting sudden symptom, such as pain or dysfunction for less than 3 months. Three of those cases [29, 30, 31] did not have a description of the clinical history of the chief complaint, while the remaining 59 patients have been experiencing chronic signs and symptoms for several years. At the time of diagnosis, 83.7% of patients (62 out of 74) reported experiencing pain. Additionally, 71.6% (53 out of 74) exhibited both objective (a decrease in interincisal distance to less than 35 mm) and subjective mouth-opening limitation. Swelling was the third most common clinical sign, observed in 40.54% of patients, with 30 out of 74 individuals experiencing this symptom. Furthermore, 14 patients [16, 17, 28, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42] were referred for hearing loss, which was confirmed in all cases by instrumental analysis. Finally, a total of 11 patients [23, 35, 43, 44, 45, 46, 47, 48, 49, 50], which accounts for 14.86% of the group, reported experiencing changes in their dental occlusion. All the signs and symptoms summarized could be found in Table 2 (Ref. [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87]).

Table 2.Shows the patients referring pain, occlusal dental changes, jaw dysfunction (limited mouth opening) and hearing loss.
Study first AuthorsYearN of patientsOcclusal changesPainJaw disfunctionHearing loss
Good et al. [20]198210110
Zemplenyi et al. [29]198520110
Gross et al. [30]198730110
Hutton et al. [22]198740110
50110
60110
Kamatani et al. [43]198771010
Mogi et al. [61]198780110
Lambert et al. [32]199090011
Dijkgraaf et al. [44]1992101110
Magno et al. [33]1992110101
Chuong et al. [46]1995121110
Pynn et al. [45]1995131000
Allias-Montmayeur et al. [23]1997141110
151110
Kurihara et al. [51]1997160100
Onodera et al. [69]1997170010
Vargas et al. [70]1997180110
Jordan et al. [16]1998190001
Strobl et al. [71]1998200110
Goudot et al. [72]1999210110
Grant et al. [28]1999220111
Nakagawa et al. [73]1999230110
240100
Pynn et al. [50]1998251000
Aoyama et al. [74]2000260110
Li-Yu et al. [34]2000270111
Eriksson et al. [75]2001280110
Olin et al. [24]2001290000
Osano et al. [76]2003300110
Marsot-Dupuch et al. [35]2004311111
320111
Meul et al. [77]2005330110
Smolka et al. [25]2005340110
Nicholas et al. [52]2007350100
Mikami et al. [78]2008360100
Naqvi et al. [36]2008370101
Reynolds et al. [79]2008380110
Covani et al. [9]2009390110
Kathju et al. [80]2010400110
Meng et al. [47]2011411110
Sklenicka et al. [26]2011420110
Matsumura et al. [81]2012430110
Nelson et al. [31]2012440100
Srinivasan et al. [27]2012450010
Zweifel et al. [48]2012461100
Lv et al. [17]2013470001
Abdelsayed et al. [37]2014480110
490111
500100
Laviv et al. [54]2015510110
Kudoh et al. [18]2017520110
Fuentes-Martinez et al. [62]2018530100
Kwon et al. [82]2018540110
Vellone et al. [83]2018550110
De Jong et al. [38]2019560101
Fan et al. [39]2019570111
Sha et al. [84]2019580100
Abou-Foul et al. [53]2020590110
Choi et al. [19]2020600110
610110
620110
Gomez Serrano et al. [40]2020630001
Hotokezaka et al. [10]2020640110
Houghton et al. [85]2020650000
Loro et al. [86]2020660110
Tang et al. [41]2021670110
680101
Bschorer et al. [8]2022690100
Dang et al. [49]2022701110
Murahashi et al. [87]2022710110
Takeda et al. [63]2022720110
Terauchi et al. [55]2022730110
Bukawa et al. [21]2023740010
Legend: 0: not present; 1: present.

4.3 Blood exam

Blood tests were conducted on 28 patients as listed in Table 3 (Ref. [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87]). The majority of patients had normal biochemistry results, except for a few exceptions:

- Kurihara et al. [51] observed a very slight elevation of hyperuricemia;

- Grant et al. [28] highlighted elevated levels of serum calcium; ionized calcium; parathyroid hormone; and a low phosphate level;

- Nicholas et al. [52] demonstrated an elevated intact parathyroid hormone level and hypocalcemia;

- Meng et al. [47] reported a slightly higher phosphate and cholesterol;

- Abou-Foul et al. [53] identified a slightly elevated parathyroid hormone.

Table 3.Summary of blood examination.
Study first AuthorYearN of patientsBlood exams
Good et al. [20]19821Normal biochemistry
Zemplenyi et al. [29]19852Normal biochemistry
Gross et al. [30]19873Not reported
Hutton et al. [22]19874Not reported
5Not reported
6Not reported
Kamatani et al. [43]19877Normal biochemistry
Mogi et al. [61]19878Normal biochemistry
Lambert et al. [32]19909Normal biochemistry
Dijkgraaf et al. [44]199210Not reported
Magno et al. [33]199211Not reported
Chuong et al. [46]199512Not reported
Pynn et al. [45]199513Not reported
Allias-Montmayeur et al. [23]199714Not reported
15Not reported
Kurihara et al. [51]199716Slight hyperuricemia (8.1 mg/dL)
Onodera et al. [69]199717Not reported
Vargas et al. [70]199718Not reported
Jordan et al. [16]199819Not reported
Strobl et al. [71]199820Normal biochemistry
Goudot et al. [72]199921Normal biochemistry
Grant et al. [28]199922Normal biochemistry except for elevated levels of serum calcium (11.9 mg/dL; normal range 8.9–10.2 mg/dL); ionized calcium (1.38 mmol/L; normal range 1.16–1.27 mmol/L); parathyroid hormone (122 pg/mL; normal range 21–69 pg/mL); and a low phosphate level (2.8 mg/dL; normal range 3–4.5 mg/dL)
Nakagawa et al. [73]199923Normal biochemistry
24Not reported
Pynn et al. [50]199825Not reported
Aoyama et al. [74]200026Not reported
Li-Yu et al. [34]200027Normal biochemistry except for an elevated erythrocyte sedimentation rate of 66 mm/hr
Eriksson et al. [75]200128Not reported
Olin et al. [24]200129Not reported
Osano et al. [76]200330Normal biochemistry
Marsot-Dupuch et al. [35]200431Not reported
32Not reported
Meul et al. [77]200533Normal biochemistry
Smolka et al. [25]200534Normal biochemistry
Nicholas et al. [52]200735Elevated intact parathyroid hormone level and hypocalcemia with no other metabolic abnormalities.
Mikami et al. [78]200836Not reported
Naqvi et al. [36]200837Not reported
Reynolds et al. [79]200838Normal biochemistry except for slight elevation in erythrocyte sedimentation rate to 22 (upper limit of normal 21)
Covani et al. [9]200939Normal biochemistry
Kathju et al. [80]201040Not reported
Meng et al. [47]201141Normal biochemistry except for lightly higher phosphate, 1.49 mmol/L (normal 0.81–1.46) and cholesterol 5.89 mmol/L (normal 3.10– 5.70)
Sklenicka et al. [26]201142Not reported
Matsumura et al. [81]201243Normal biochemistry, except for a positive hepatitis virus Type B infection
Nelson et al. [31]201244Not reported
Srinivasan et al. [27]201245Not reported
Zweifel et al. [48]201246Normal biochemistry
Lv et al. [17]201347Normal biochemistry
Abdelsayed et al. [37]201448Not reported
49Not reported
50Not reported
Laviv et al. [54]201551Normal biochemistry
Kudoh et al. [18]201752Not reported
Fuentes-Martinez et al. [62]201853Not reported
Kwon et al. [82]201854Not reported
Vellone et al. [83]201855Normal biochemistry
De Jong et al. [38]201956Not reported
Fan et al. [39]201957Not reported
Sha et al. [84]201958Normal biochemistry
Abou-Foul et al. [53]202059Slightly elevated parathyroid hormone but otherwise normal biochemistry
Choi et al. [19]202060Not reported
61Not reported
62Not reported
Gomez Serrano et al. [40]202063Not reported
Hotokezaka et al. [10]202064Not reported
Houghton et al. [85]202065Normal biochemistry
Loro et al. [86]202066Normal biochemistry
Tang et al. [41]202167Not reported
68Not reported
Bschorer et al. [8]202269Not reported
Dang et al. [49]202270Normal biochemistry
Murahashi et al. [87]202271Normal biochemistry
Takeda et al. [63]202272Normal biochemistry
Terauchi et al. [55]202273Normal biochemistry
Bukawa et al. [21]202374Not reported

4.4 Radiological examination

In Table 4, the radiological examinations performed for the 74 patients were reported to achieve a diagnosis. 63 out of 74 (85.13%) had been studied with CT. Out of the total number of patients, 41 exhibited condylar degeneration. However, in 33 cases, there were no radiological signs of invasion of nearby tissues. Twenty-two patients experienced temporal bone resorption, with an invasion of the skull base by CPPD and affection of the meninges in 2 cases. 8 patients experienced a local invasion in the ear canal. Finally, in 2 cases, the Magnetic Resonance (MRI) revealed an involvement of the parotid gland by the neoformation.

In 9 cases [18, 21, 22, 23, 30, 44, 52] CPPD lesions were also identified in various joints, with knee and wrist being the most commonly involved.

Table 4.Radiological examination performed to study CPPD.
Radiological ExaminationN of Patients
Only CT30
Only MRI4
Both CT and MRI29
Ultrasound0
RX (orthopantomography)7
Both CT and RX4
Legend: CT: computerized tomography; MRI: Magnetic Resonance; RX: Radiography.

4.5 Diagnosis of CPPD

Out of the total 74 cases of CPPD, only three Authors [18, 22, 55] were able to identify it through radiological examination. In 21 cases, joint aspiration was performed to complete the diagnostic process. In 50 patients, the diagnostic process itself served as the treatment solution with complete removal of the lesion.

4.6 Treatment, relapse and follow-up

Table 5 reports the various methods used by different Authors to treat CPPD. The surgical approach is the most common, with varying degrees of invasiveness. The three papers that managed patients solely with drugs utilized different solutions.

Table 5.Various methods used to treat CPPD.
Type of TreatmentN of Patients
Only Follow-up12
Medications3
Surgical removal of the lesion26
Arthroplasty and removal of the lesion13
Condylectomy, removal of the lesion and joint reconstruction16
Massive demolition (condyle, glenoid fossa, zygomatic arch, muscles…) and joint reconstruction4

- In the study by Good et al. [20] Indomethacin, administered at a dosage of 25 mg four times daily, was found to provide relief from pain within a few hours.

- Choi et al. [19] treated one of the three patients with colchicine without benefit, but reported an improvement with non-steroidal anti-inflammatory drugs (NSAIDs) during acute exacerbations. The second case in their case series was treated with a steroid injection in the TMJ. In both cases the pharmacological treatment was not detailed.

Only one relapse of CPPD was reported, in the paper of Dijkgraaf et al. [44], whose patient underwent arthroplasty and surgical removal of the lesion. However, after one year, he received further treatment which involved the insertion of temporalis fascia. This resulted in the resolution of symptoms and an improvement in function. Patients who only received follow-up or pharmacological treatment did not experience any changes in the lesion or symptoms during the follow-up period.

The follow-up period averaged 13.45 ± 23 months.

5. Discussion

A systematic assessment of the literature on CPPD of the TMJ over the past decades allowed the identification of 61 new cases since the last comprehensive review by Pynn et al. [45], thus reaching a total of 75 cases, included the case reported in this manuscript. It is common for studies to focus on individual cases, with only a small number of publications describing multiple cases (only 6 out of 74). The current review assessed systematically all available publications from 1980 to date, providing a standpoint for describing the disease’s epidemiological characteristics.

Pseudogout, also known as Calcium pyrophosphate dihydrate deposition disease (CPPD), is a metabolic condition characterized by the accumulation of calcium pyrophosphate dihydrate crystals in the synovial fluid. This accumulation leads to the calcification of articular cartilage and can cause acute arthritis in a small subset of patients [56]. Various etiologies were proposed [57]: Hereditary, Sporadic (idiopathic), Associated with metabolic disease (Hyperparathyroidism, reaching, Hypophosphatasia, Rheumatoid arthritis, Hemochromatosis, Hypomagnesemia and Renal failure), Associated with trauma or surgery.

CPPD often develops in joints containing fibrocartilage such as the knee, wrist, hip, shoulder and elbow. While involvement in the TMJ is rare, it is common to find lesions larger than 1 cm. In some cases, the crystals cause complete destruction of the joint space and invade surrounding structures: masticator space, parotid space and skull base [58].

5.1 Population’s characteristics

CPPD is usually of interest to middle-aged or older patients [45], as confirmed by their average age at the time of diagnosis reported in this review, which is around 60 years. Additionally, females are affected 1.6 times more frequently by this condition than males, and this trend has remained consistent across recent and past studies. The vast majority of cases (around 95%) showed a unilateral TMJ involvement as reported by Tamimi et al. [58].

5.2 Signs and symptoms and blood test evaluation

The most common symptoms of this condition include pain (83.7% of patients), reduced mouth opening (71.6%), and swelling (40.5% of patients). Additionally, there are less common symptoms such as hearing loss (18.9%) and changes in dental occlusion (14.8%). These are common clinical manifestations of various temporomandibular joint disorders, such as chondromatosis of the TMJ [59], so that differential diagnosis may be a concern that explains a potential late diagnosis [60].

There are no frequently altered blood tests; the few papers [28, 47, 51, 52, 53] that had studied the patient by a hematological point of view reported only minimal variations that are not relevant for diagnostic purposes.

5.3 Radiological examination

Imaging techniques such as MRI and CT can be useful in identifying joint changes. These techniques can also reveal the presence of cloud-like synovial calcification in cases of early/mild CPPD. In late/severe stages, a chunky, diffusely calcified mass with a ground-glass appearance may be detected [58]. MRI can be used to accurately detect the presence of calcification in early CPPD, while in severe stages with invasion of muscles [43, 61], parotid gland [29] and even brain structure [16], aiding in identifying soft tissue involvement and planning surgical treatment.

Williams et al. [57] had reported that TMJ is more commonly involved than previously reported in patients affected by peripheral calcific disease, with a higher ratio females:males. This was confirmed by 9 Authors [18, 20, 22, 23, 30, 44, 54] who showed the presence of a synchronous involvement of different major joints, in particular the knee and the wrist.

5.4 Treatment, relapse and follow-up

The presence of multiple crystals of calcium pyrophosphate dihydrate in the joint space can disrupt its function and may require surgical removal. This review found that out of 74 cases, 59 were treated surgically using various methods such as removal of the lesion, arthroplasty with lesion removal, condylectomy with joint replacement, and complete demolition with joint replacement. It is difficult to determine the superiority of any method over another due to the heterogeneity of the study samples in terms of type, duration, and size of the lesion. Additionally, early stage lesions may just be monitored during follow-up or treated with medication based on symptoms or joint lavage, which showed a very good effectiveness for several TMJ internal derangements [18, 19, 20, 21, 22, 35, 37, 39, 62, 63, 64, 65].

5.5 Limitations

The included source studies exhibited heterogeneity in terms of diagnosis, treatment and follow-up, making it more suitable to conduct separate meta-analyses for the diagnosis/prevalence of CPPD in the TMJ and the different outcomes of treatment. However, the limited number of studies in this systematic review precludes their division into subgroups. The search was conducted in English, potentially resulting in the omission of records unindexed with English keywords. Due to the scarcity of source material, studies with uncertain and high risk of bias were included in the synthesis.

5.6 Strengths

The strengths of this systematic review encompass the meticulous definition of eligibility criteria, the comprehensive nature of the search, and strict adherence to PRISMA guidelines.

The case report outlined in this paper has many similarities to the other cases described in the literature. Late diagnosis was a common theme, as suggested by previous research, and it must be remarked that dentists unfortunately play a negative role due to the focus on oral appliance treatment and/or occlusal approaches as a one-fits-all approach to all TMJ disorders [12, 66]. Such a concern was also pointed out in previous papers on late-stage surgical demanding lesions [67]. Imaging techniques were used to have an accurate depiction of the joint status and plan for surgery, in line with current standards [68]. Open surgery was chosen as the best option to remove the sizable lesion detected with CT. The postoperative recovery was smooth, indicating a positive prognosis and successful treatment outcome, consistent with other instances of CPPD of the TMJ.

As a general remark, data reported in this review could help researchers pinpoint areas for improvement in future studies. To enhance knowledge on CPPD of the TMJ, there must be better quality literature on the disease. Many case reports lacked information on the disease stages as well as detailed surgical technique descriptions. Future research should aim to furnish comprehensive details regarding the patient’s medical history, encompassing anamnesis and the duration of symptoms. This approach is essential for identifying potential risk factors associated with the onset and progression of the disease.

6. Conclusions

In conclusion, CPPD is a rare and locally invasive benign disease that seldom affects the TMJ. A case report of a patient exhibiting classic CPPD symptoms has been presented, along with a comprehensive review of related literature from the past few decades. The review included 74 cases of CPPD in the TMJ, with a ratio of 1.6 females to every male and an average age of around 60 years. Bilateral localization was observed only in four cases. Although all cases showed varying degrees of hard and soft tissue invasion, thus making it not possible to generalize findings, there is a lack of information regarding the relationship between a possible extra-articular extension and time. In any case, late diagnosis is a common concern due to the often-unspecific symptoms. While surgery has the preferred treatment option for most of the authors and is mandatory for late stage lesions, a conservative approach may be considered in the early stages. The recurrence rate is extremely low, with only one case reported in the literature.

This review has demonstrated its efficacy in establishing the correct pathway for the diagnosis and management of suspected TMJ CPPD cases.

Further research is needed to establish a disease staging system based on the involvement of both articular and extra-articular tissues. This will, in turn, facilitate the standardization of TMJ CPPD treatment according to the localized invasiveness of the lesion.

Availability of data and materials

Data are available upon reasonable request.

Author contributions

MV, DM, AC and LGN—wrote and organized the article; MF, EFC and MR—revised and edited the article; LGN, DM—designed the retrospective analysis; LGN, MR and MV—treated and performed the follow-up of the patient. All authors participated in the analysis of the literature.

Ethics approval and consent to participate

The protocol for studying temporomandibular disorders and their surgical treatment was approved in 2018 at the Maxillofacial Surgery Unit of Ca’Foncello Hospital in Treviso (Italy). Ethical Committee approval numbered 581/CE Marca. Informed consent to participate in the study was obtained from participant.

Acknowledgment

Thanks for the histopathological examination of the specimen to Francesca Baciorri from the Department of Pathology and Molecular Genetics at the University of Padova’s Ca’ Foncello Hospital in Treviso, Italy.

Funding

This research received no external funding.

Conflict of interest

The authors declare no conflict of interest.

Supplementary material

Supplementary material associated with this article can be found, in the online version, at https://files.jofph.com/ files/article/1899699082825220096/attachment/ Supplementary%20material.docx.

References

Atzeni F, Sarzi-Puttini P, Bevilacqua M. Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others). Rheumatic Disease Clinics of North America. 2006; 32: 413–426.

[Google Scholar]

Kohn NN, Hughes RE, Mc CD Jr, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome”. II. Identification of crystals. Annals of Internal Medicine. 1962; 56: 738–745.

[Google Scholar]

Richette P, Bardin T, Doherty M. An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. Rheumatology. 2009; 48: 711–715.

[Google Scholar]

Iacopino AM, Wathen WF. Craniomandibular disorders in the geriatric patient. Journal of Orofacial Pain. 1993; 7: 38–53.

[Google Scholar]

Willekens I, Fares A, Devos H, Shahabpour M, Lenchik L, Buls N, et al. Prevalence of chondrocalcinosis in the temporomandibular joint in patients with chondrocalcinosis of the knee or wrist. Dentomaxillofacial Radiology. 2020; 49: 20190450.

[Google Scholar]

Parrino D, Val M, Lovato A, de Filippis C, Nardini LG. Pediatric temporomandibular joint ankylosis and arthritis: forgotten complications of acute otitis media. American Journal of Otolaryngology. 2022; 43: 103599.

[Google Scholar]

Nardini LG, Val M, Colonna A, Cagidiaco EF, Ferrari M, Manfredini D. Treatment of condylar hypoplasia in alagille syndrome—a case report. Annals of Maxillofacial Surgery. 2024; 14: 85–88.

[Google Scholar]

Bschorer F, Höller S, Baumhoer D, Bschorer R. Pseudogout growing from the temporomandibular joint into the middle cranial fossa. Oral and Maxillofacial Surgery. 2024; 28: 441–445.

[Google Scholar]

Covani U, Orlando B, Galletti C, Nuterini C, Barone A. Chondrocalcinosis of the temporomandibular joint: clinical considerations and case report. Cranio. 2009; 27: 134–139.

[Google Scholar]

Hotokezaka Y, Hotokezaka H, Katayama I, Fujita S, Sasaki M, Eida S, et al. A case of tophaceous pseudogout of the temporomandibular joint extending into the cranium. Oral Radiology. 2020; 36: 203–208.

[Google Scholar]

Pentenero M, Val M, Rosso S, Gandolfo S. Microbiopsy a first-level diagnostic test to rule out oral dysplasia or carcinoma in general dental practice. Oral Diseases. 2018; 24: 109–111.

[Google Scholar]

Greene CS, Manfredini D. Transitioning to chronic temporomandibular disorder pain: a combination of patient vulnerabilities and iatrogenesis. Journal of Oral Rehabilitation. 2021; 48: 1077–1088.

[Google Scholar]

Greene CS, Manfredini D. Overtreatment “Successes”—what are the negative consequences for patients, dentists, and the profession? Journal of Oral & Facial Pain and Headache. 2023; 37: 81–90.

[Google Scholar]

Sorrenti NG, Manfredini D, Sornig F, Ferrari M, Colonna A, Val M. Correlation between bilateral TMJ MRI findings: a systematic review of the literature. Dental and Medical Problems. 2024; 61: 401–406.

[Google Scholar]

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic Reviews. 2021; 10: 89.

[Google Scholar]

Jordan JA, Roland P, Lindberg G, Mendelsohn D. Calcium pyrophosphate deposition disease of the temporal bone. Annals of Otology, Rhinology & Laryngology. 1998; 107: 912–916.

[Google Scholar]

Lv H, Fan Z, Han Y, Xu L, Wang H. A case of pseudogout of the temporomandibular joint with giant cell reparative granuloma of the temporal bone. American Journal of Otolaryngology. 2013; 34: 762–765.

[Google Scholar]

Kudoh K, Kudoh T, Tsuru K, Miyamoto Y. A case of tophaceous pseudogout of the temporomandibular joint extending to the base of the skull. International Journal of Oral and Maxillofacial Surgery. 2017; 46: 355–359.

[Google Scholar]

Choi DD, Smith D, Davis CM, McCain JP. Arthroscopic diagnosis and medical management of calcium pyrophosphate deposition disease in the temporomandibular joint. International Journal of Oral and Maxillofacial Surgery. 2020; 49: 1618–1621.

[Google Scholar]

Good AE, Upton LG. Acute temporomandibular arthritis in a patient with bruxism and calcium pyrophosphate deposition disease. Arthritis & Rheumatology. 1982; 25: 353–355.

[Google Scholar]

Bukawa K, Fukuzawa S, Yamagata K, Uchida F, Ishibashi-Kanno N, Nagai H, et al. A case of tophaceous pseudogout with destruction of the skull base at the temporomandibular joint. Indian Journal of Otolaryngology and Head & Neck Surgery. 2023; 75: 1109–1113.

[Google Scholar]

Hutton CW, Doherty M, Dieppe PA. Acute pseudogout of the temporomandibular joint: a report of three cases and review of the literature. British Journal of Rheumatology. 1987; 26: 51–52.

[Google Scholar]

Allias-Montmayeur F, Durroux R, Dodart L, Combelles R. Tumours and pseudotumorous lesions of the temporomandibular joint: a diagnostic challenge. The Journal of Laryngology & Otology. 1997; 111: 776–781.

[Google Scholar]

Olin HB, Pedersen K, Francis D, Hansen H, Poulsen FW. A very rare benign tumour in the parotid region: calcium pyrophosphate dihydrate crystal deposition disease. The Journal of Laryngology & Otology. 2001; 115: 504–506.

[Google Scholar]

Smolka W, Eggensperger N, Stauffer-Brauch EJ, Brekenfeld C, Iizuka T. Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint. Oral Diseases. 2005; 11: 104–108.

[Google Scholar]

Sklenicka S, Dierks EJ, Jarmin J, Miles C. Pseudogout of the temporomandibular joint: an uncommon cause of temporomandibular joint pain and swelling. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2011; 111: 709–714.

[Google Scholar]

Srinivasan V, Wensel A, Dutcher P, Newlands S, Johnson M, Vates GE. Calcium pyrophosphate deposition disease of the temporomandibular joint. Journal of Neurological Surgery Reports. 2012; 73: 6–8.

[Google Scholar]

Grant GA, Wener MH, Yaziji H, Futran N, Bronner MP, Mandel N, et al. Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature. Journal of Neurosurgery. 1999; 90: 148–152.

[Google Scholar]

Zemplenyi J, Calcaterra TC. Chondrocalcinosis of the temporomandibular joint. A parotid pseudotumor. Archives of Otorhinolaryngology. 1985; 111: 403–405.

[Google Scholar]

Gross BD, Williams RB, DiCosimo CJ, Williams SV. Gout and pseudogout of the temporomandibular joint. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 1987; 63: 551–554.

[Google Scholar]

Nelson RF, Dursteler B, Smith RB. Pathology quiz case 2. Tophaceous pseudogout (calcium pyrophosphate deposition disease [CPDD]) of the TMJ. Archives of Otorhinolaryngology-Head & Neck Surgery. 2012; 138: 873–875.

[Google Scholar]

Lambert RG, Becker EJ, Pritzker KP. Case report 597: calcium pyrophosphate deposition disorder (CPPD) of the right temporomandibular joint. Skeletal Radiology. 1990; 19: 139–141.

[Google Scholar]

Magno WB, Lee SH, Schmidt J. Chondrocalcinosis of the temporomandibular joint: an external ear canal pseudotumor. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 1992; 73: 262–265.

[Google Scholar]

Li-Yu J, Schumacher HR Jr, Gratwick G. Invasive tophaceous pseudogout in the temporomandibular joint: misdiagnosis as tumor: case report and review of the literature. Journal of Clinical Rheumatology. 2000; 6: 272–277.

[Google Scholar]

Marsot-Dupuch K, Smoker WR, Gentry LR, Cooper KA. Massive calcium pyrophosphate dihydrate crystal deposition disease: a cause of pain of the temporomandibular joint. American Journal of Neuroradiology. 2004; 25: 876–879.

[Google Scholar]

Naqvi AH, Abraham JL, Kellman RM, Khurana KK. Calcium pyrophosphate dihydrate deposition disease (CPPD)/Pseudogout of the temporomandibular joint—FNA findings and microanalysis. CytoJournal. 2008; 5: 8.

[Google Scholar]

Abdelsayed RA, Said-Al-Naief N, Salguerio M, Holmes J, El-Mofty SK. Tophaceous pseudogout of the temporomandibular joint: a series of 3 cases. Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology. 2014; 117: 369–375.

[Google Scholar]

De Jong M, Candanedo C, Keidar Haran T, Kaufman M. A curious case of crystal deposit disease in the petrous bone. Cureus. 2019; 11: e6375.

[Google Scholar]

Fan J, Heimann A, Wu M. Temporal mandibular joint chondrocalcinosis (tophaceous pseudogout) diagnosed by ultrasound-guided fine-needle aspiration. Diagnostic Cytopathology. 2019; 47: 803–807.

[Google Scholar]

Gomez Serrano M, Anne Watson N, Selvadurai D. A description of unilateral conductive hearing loss from pseudogout: a case report and review of the literature. JRSM Open. 2020; 11: 2054270419894818.

[Google Scholar]

Tang T, Han FG. Calcium pyrophosphate deposition disease of the temporomandibular joint invading the middle cranial fossa: two case reports. World Journal of Clinical Cases. 2021; 9: 2662–2670.

[Google Scholar]

Val M, Delcanho R, Ferrari M, Guarda Nardini L, Manfredini D. Is botulinum toxin effective in treating orofacial neuropathic pain disorders? A systematic review. Toxins. 2023; 15: 541.

[Google Scholar]

Kamatani Y, Tagawa T, Hirano Y, Nomura J, Murata M. Destructive calcium pyrophosphate dihydrate temporo-mandibular arthropathy (pseudogout). International Journal of Oral and Maxillofacial Surgery. 1987; 16: 749–752.

[Google Scholar]

Dijkgraaf LC, De Bont LG, Liem RS. Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: report of a case. Journal of Oral and Maxillofacial Surgery. 1992; 50: 1003–1009.

[Google Scholar]

Pynn BR, Weinberg S, Irish J. Calcium pyrophosphate dihydrate deposition disease of the temporomandibular joint. A case report and review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 1995; 79: 278–284.

[Google Scholar]

Chuong R, Piper MA. Bilateral pseudogout of the temporomandibular joint: report of case and review of literature. Journal of Oral and Maxillofacial Surgery. 1995; 53: 691–694.

[Google Scholar]

Meng J, Guo C, Luo H, Chen S, Ma X. A case of destructive calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: a diagnostic challenge. International Journal of Oral and Maxillofacial Surgery. 2011; 40: 1431–1437.

[Google Scholar]

Zweifel D, Ettlin D, Schuknecht B, Obwegeser J. Tophaceuos calcium pyrophosphate dihydrate deposition disease of the temporomandibular joint: the preferential site? Journal of Oral and Maxillofacial Surgery. 2012; 70: 60–67.

[Google Scholar]

Dang RR, Noonan V, Chigurupati R, Henry A. Treatment of tophaceous pseudogout in the temporomandibular joint with resection and alloplastic reconstruction: a single-staged approach. Oral and Maxillofacial Surgery. 2022; 26: 505–509.

[Google Scholar]

Pynn BR, Irish J, Weinberg S. Pre-auricular swelling and malocclusion. Postgraduate Medical Journal. 1998; 74: 276–279.

[Google Scholar]

Kurihara K, Mizuseki K, Saiki T, Wakisaka H, Maruyama S, Sonobe J. Tophaceous pseudogout of the temporomandibular joint: report of a case. Pathology International. 1997; 47: 578–580.

[Google Scholar]

Nicholas BD, Smith JL 2nd, Kellman RM. Calcium pyrophosphate deposition of the temporomandibular joint with massive bony erosion. Journal of Oral and Maxillofacial Surgery. 2007; 65: 2086–2089.

[Google Scholar]

Abou-Foul AK, Saeed NR. Treatment of calcium pyrophosphate deposition in the temporomandibular joint with resection and simultaneous reconstruction using a custom joint prosthesis. Oral and Maxillofacial Surgery. 2020; 24: 235–238.

[Google Scholar]

Laviv A, Sadow PM, Keith DA. Pseudogout in the temporomandibular joint with imaging, arthroscopic, operative, and pathologic findings. Report of an unusual case. Journal of Oral and Maxillofacial Surgery. 2015; 73: 1106–1112.

[Google Scholar]

Terauchi M, Uo M, Fukawa Y, Yoshitake H, Tajima R, Ikeda T, et al. Chemical diagnosis of calcium pyrophosphate deposition disease of the temporomandibular joint: a case report. Diagnostics. 2022; 12: 651.

[Google Scholar]

McCarty DJ. Pseudogout and pyrophosphate metabolism. Advances in Internal Medicine. 1980; 25: 363–390.

[Google Scholar]

Williams CJ, Rosenthal AK. Pathogenesis of calcium pyrophosphate deposition disease. Best Practice & Research Clinical Rheumatology. 2021; 35: 101718.

[Google Scholar]

Tamimi D. Specialty imaging: temporomandibular joint and sleep-disordered breathing. 2nd edn. Elsevier Health Sciences: Amsterdam. 2023.

[Google Scholar]

Guarda-Nardini L, Piccotti F, Ferronato G, Manfredini D. Synovial chondromatosis of the temporomandibular joint: a case description with systematic literature review. International Journal of Oral and Maxillofacial Surgery. 2010; 39: 745–755.

[Google Scholar]

Roy WA. Temporomandibular disorders: an evidence-based approach to diagnosis and treatment. Physical Therapy. 2006; 86: 1451–1452.

[Google Scholar]

Mogi G, Kuga M, Kawauchi H. Chondrocalcinosis of the temporomandibular joint. Calcium pyrophosphate dihydrate deposition disease. Archives of Otorhinolaryngology-Head & Neck Surgery. 1987; 113: 1117–1119.

[Google Scholar]

Fuentes-Martinez N, Tani E, Darai-Ramqvist E, Skoog L. Case report: calcium pyrophosphate dihydrate deposition of the temporomandibular joint diagnosed by fine-needle aspiration cytology. Diagnostic Cytopathology. 2018; 46: 610–612.

[Google Scholar]

Takeda K, Miyamoto I, Abe R, Kawai T, Ohashi Y, Yamada H. Tophaceous pseudogout of the temporomandibular joint extending into the cranium: a case report with literature review. Journal of Surgical Case Reports. 2022; 2022: rjac055.

[Google Scholar]

Guarda-Nardini L, De Almeida AM, Manfredini D. Arthrocentesis of the temporomandibular joint: systematic review and clinical implications of research findings. Journal of Oral & Facial Pain and Headache. 2021; 35: 17–29.

[Google Scholar]

Guarda-Nardini L, Meneghini M, Zegdene S, Manfredini D. Temporomandibular Joint arthrocentesis in patients with degenerative joint disease: a 10- to 22-year follow-up. Journal of Oral & Facial Pain and Headache. 2021; 35: 113–118.

[Google Scholar]

Greene CS, Manfredini D. Treating temporomandibular disorders in the 21st century: can we finally eliminate the “third pathway”? Journal of Oral & Facial Pain and Headache. 2020; 34: 206–216.

[Google Scholar]

Guarda-Nardini L, Stellini E, Di Fiore A, Manfredini D. A rare case of misdiagnosed silent lung cancer with solitary metastasis to the temporomandibular joint condyle. Journal of Oral & Facial Pain and Headache. 2017; 31: 180–185.

[Google Scholar]

Val M, Ragazzo M, Bendini M, Manfredini D, Trojan D, Guarda Nardini L. Computer-assisted surgery with custom prostheses and human amniotic membrane in a patient with bilateral class IV TMJ reankylosis: a case report. Cell and Tissue Banking. 2022; 23: 395–400.

[Google Scholar]

Onodera K, Ichinohasama R, Saito M, Ooya K. A case of the calcium pyrophosphate dihydrate (CPPD) deposition disease without condylar destruction of the temporomandibular joint. Pathology International. 1997; 47: 622–626.

[Google Scholar]

Vargas A, Teruel J, Trull J, López E, Pont J, Velayos A. Calcium pyrophosphate dihydrate crystal deposition disease presenting as a pseudotumor of the temporomandibular joint. European Radiology. 1997; 7: 1452–1453.

[Google Scholar]

Strobl H, Emshoff R, Kreczy A. Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 1998; 85: 349–351.

[Google Scholar]

Goudot P, Jaquinet A, Gilles R, Richter M. A destructive calcium pyrophosphate dihydrate deposition disease of the temporomandibular joint. Journal of Craniofacial Surgery. 1999; 10: 385–388.

[Google Scholar]

Nakagawa Y, Ishibashi K, Kobayashi K, Westesson PL. Calcium pyrophosphate deposition disease in the temporomandibular joint: report of two cases. Journal of Oral and Maxillofacial Surgery. 1999; 57: 1357–1363.

[Google Scholar]

Aoyama S, Kino K, Amagasa T, Kayano T, Ichinose S, Kimijima Y. Differential diagnosis of calcium pyrophosphate dihydrate deposition of the temporomandibular joint. British Journal of Oral and Maxillofacial Surgery. 2000; 38: 550–553.

[Google Scholar]

Eriksson L, Mertens F, Akerman M, Wiegant J. Calcium pyrophosphate dihydrate crystal deposition disease in the temporomandibular joint: diagnostic difficulties and clonal chromosome aberrations in a case followed up for 5 years. Journal of Oral and Maxillofacial Surgery. 2001; 59: 1217–1220.

[Google Scholar]

Osano H, Matsumoto K, Kusama M. Calcium pyrophosphate dihydrate arthropathy with condylar destruction of the temporomandibular joint. Journal of Oral Science. 2003; 45: 223–226.

[Google Scholar]

Meul B, Ernestus K, Neugebauer J, Kuebler AC. A case of chronic calcium pyrophosphate dihydrate crystal disease (tophaceous pseudogout) in the temporomandibular joint. Oral Diseases. 2005; 11: 113–115.

[Google Scholar]

Mikami T, Takeda Y, Ohira A, Hoshi H, Sugiyama Y, Yoshida Y, et al. Tumoral calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint: identification on crystallography. Pathology International. 2008; 58: 723–729.

[Google Scholar]

Reynolds JL, Matthew IR, Chalmers A. Tophaceous calcium pyrophosphate dihydrate deposition disease of the temporomandibular joint. The Journal of Rheumatology. 2008; 35: 717–721.

[Google Scholar]

Kathju S, Cohen R, Lasko LA, Aynechi M, Dattilo DJ. Pseudogout of the temporomandibular joint: immediate reconstruction with total joint arthroplasty. Head & Neck. 2010; 32: 406–410.

[Google Scholar]

Matsumura Y, Nomura J, Nakanishi K, Yanase S, Kato H, Tagawa T. Synovial chondromatosis of the temporomandibular joint with calcium pyrophosphate dihydrate crystal deposition disease (pseudogout). Dentomaxillofacial Radiology. 2012; 41: 703–707.

[Google Scholar]

Kwon KJ, Seok H, Lee JH, Kim MK, Kim SG, Park HK, et al. Calcium pyrophosphate dihydrate deposition disease in the temporomandibular joint: diagnosis and treatment. Maxillofacial Plastic and Reconstructive Surgery. 2018; 40: 19.

[Google Scholar]

Vellone V, Bracciolini V, Ramieri V, Pernazza A, Della Rocca C, Cascone P. Synovial chondromatosis and calcium pyrophosphate deposition of the temporomandibular joint: challenging diagnosis. Journal of Craniofacial Surgery. 2018; 29: e792–e794.

[Google Scholar]

Sha Y, Hong K, Liew MKM, Lum JL, Wong RCW. Juxta-articular tumoral calcinosis associated with the temporomandibular joint: a case report and concise review. BMC Oral Health. 2019; 19: 138.

[Google Scholar]

Houghton D, Munir N, Triantafyllou A, Begley A. Tophaceous pseudogout of the temporomandibular joint with erosion into the middle cranial fossa. International Journal of Oral and Maxillofacial Surgery. 2020; 49: 1286–1289.

[Google Scholar]

Loro LL, Bjørnland T. Calcium pyrophosphate deposition disease: a case report with bilateral involvement of the temporomandibular joints and concurrence of psoriatic arthritis. Clinical Case Reports. 2020; 8: 640–643.

[Google Scholar]

Murahashi M, Ntege EH, Higa M, Maruyama N, Kawano T, Shimizu Y, et al. Management of temporomandibular joint diseases: a rare case report of coexisting calcium pyrophosphate crystal deposition and synovial chondromatosis. BMC Oral Health. 2022; 22: 662.

[Google Scholar]